Boryung Pharmaceutical Reports Q1 Operating Profit of 13.8 Billion KRW, Up 2.7% Year-on-Year
[Asia Economy Reporter Park Jihwan] Boryung Pharmaceutical announced on the 26th that its provisional operating profit for the first quarter of this year was 13.8 billion KRW, an increase of 2.65% compared to the same period last year.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051414165763158_1778735817.jpg)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- [Breaking] Two Days Before Strike... Central Labor Relations Commission Chair Park Soogeun Says "Differences Narrowing... Possibility of Agreement"
- Individual Investors Absorb Foreign Sell-Off... Concerns Over Becoming "Cannon Fodder" Emerge
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
During the same period, sales revenue increased by 1.21% to 135.8 billion KRW. Net profit rose by 106% to 17.1 billion KRW.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
